Overview of Ursodeoxycholic Acid JG
Quick Facts About Ursodeoxycholic Acid
| Property | Description |
|---|---|
| Active ingredient | Ursodeoxycholic acid (UDCA), also known as Ursodiol |
| Form | Oral solid dosage (Capsules or tablets) |
| Pharmacological class | Hepatoprotective agent, Cholelitholytic agent |
| Common use | Modulating bile composition and promoting bile flow |
| Origin | Derived secondary bile acid, manufactured for pharmaceutical use |
What is Ursodeoxycholic Acid (Ursodiol)?
Ursodeoxycholic Acid (UDCA), the active ingredient known as Ursodiol, is a specialized secondary bile acid derivative manufactured as an oral solid dosage form for oral administration. This medication is classified as a prescription drug due to its specific mechanisms of action and required monitoring. This substance is highly hydrophilic (water-soluble) and is used therapeutically because its chemical structure is significantly less toxic than most natural bile acids present in the body.
The product designation, such as Ursodeoxycholic Acid JG, ensures a single-ingredient formulation standardized for consistent delivery. UDCA is clinically recognized for its ability to alter the balance of cholesterol saturation in bile. This confirms the medication's primary role is to protect the health of the liver and regulate the flow of bile.
What Type of Medicine is UDCA? (Pharmacological Class and Purpose)
UDCA is classified primarily as a Hepatoprotective agent and a Cholelitholytic agent. The hepatoprotective function means the medicine actively helps to stabilize and shield the cell membranes of the liver (hepatocytes) from potential damage, a key attribute in managing chronic hepato-biliary issues. The cholelitholytic action indicates its ability to influence the composition of bile itself.
Ursodeoxycholic Acid is used for conditions where its ability to change bile composition and flow is beneficial, confirming its pharmacological role. This shows the drug’s general purpose is to support the body's natural processes by improving bile quality and flow. By competing with more hydrophobic bile acids, UDCA effectively creates a safer fluid environment within the biliary tract, supporting overall liver function.
Regulatory References

